7/11/13: Quest: MDA’s Research and Health Magazine, CMD: Aiming Simultaneously at Two Biological Targets

Researchers at Boston University say their experimental two-pronged strategy for merosin-deficient congenital muscular dystrophy (MDC1A) was highly successful in a mouse model of this disease and should be further investigated as a potential treatment approach for patients.

Read the rest of this entry.